Clinical Trial
Study Details
Enrollment
10
Primary Completion
Status
RECRUITING
Study Completion
Study ID #
NCT05040373
Study Start
Study Type
Observational
Summary
The purpose of this study is to collect and evaluate pregnancy outcomes, pregnancy complications, and fetal/neonatal/infant outcomes in women exposed to patisiran-LNP.
Study Overview
Participation Criteria
Eligibility Criteria
Inclusion Criteria:
* Documentation that the patient was exposed to patisiran-LNP at any point starting from 12 weeks before LMP or at any point during pregnancy
Exclusion Criteria:
* There are no exclusion criteria for participation in this program.
Sexes Eligible for Study
FEMALE
Eligibility Std Ages
Child
Adult
Older Adult
Study Population
Any woman exposed to patisiran-LNP 12 weeks prior to their last menstrual period (LMP) or at any time during pregnancy.